Hjem › Kardiovaskulær sykdom › North Carolina
Kliniske studier for Kardiovaskulær sykdom i North Carolina
30 studier for Kardiovaskulær sykdom søker deltakere på steder i North Carolina.
Byer i North Carolina
- Durham17 studier
- Winston-Salem14 studier
- Charlotte9 studier
- Raleigh5 studier
- Greensboro5 studier
- Asheville4 studier
- Greenville3 studier
- Wilmington3 studier
Offisiell studietekst (engelsk)
ELEVATE-HFpEF Clinical Study
- Duke University Medical Center, Durham
Rekrutterer
Alder 40 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06678841CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
- Carolinas Medical Center, Charlotte
- Wake Forest University Health Sciences, Winston-Salem
Rekrutterer
Alder 21 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT05897632EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Cary Cardiology, Cary
- The University of North Carolina at Chapel Hill, Chapel Hill
- Physicians East, PA, Greenville
- og 5 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07064473Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)
- Atrium Health Wake Forest Baptist Medical Center, Winston-Salem
Rekrutterer
Alder 18 til 85 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07585968Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Asheville Cardiology Associates Research Department, Asheville
- Novant Health Clinical Research/Heart & Vascular Institute, Charlotte
- Mecklenburg Heart Specialists, Charlotte
- og 6 flere
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06909565Product Surveillance Registry
- Chapel Hill
- Charleston
- Durham
- og 3 flere
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT01524276Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Durham
- Clinical Trial Site, Greenville
- Clinical Trial Site, High Point
- og 5 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT07181109Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07685938Zenith® Fenestrated+ Clinical Study
- University of North Carolina at Chapel Hill, Chapel Hill
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT04875429Observational Pharmaco-Epidemiology Research & Analysis
- Epividian, Durham
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 0 og eldre · Alle kjønn · Oppdatert 11. sep. 2026 · NCT03813862Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- Duke University, Durham
Rekrutterer
Alder 18 til 100 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06310031An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Novant Health Heart Vas Inst, Charlotte
- Medication Management LLC, Greensboro
- Accellacare US Inc, Raleigh
- og 2 flere
RekruttererFase 3
Alder 18 til 100 · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07517263A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Greensboro
RekruttererFase 2
Alder 18 til 85 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07333183Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
- Asheville VA-Charles George VA Medical Center, Asheville
- University of North Carolina, Chapel Hill
- Atrium Health, Charlotte
- og 5 flere
RekruttererFase 4Frivillige helsepersonell ønskes velkommen
Alder 75 og eldre · Alle kjønn · Oppdatert 1. sep. 2026 · NCT04262206Cardiovascular Effects of Very Low Nicotine Content Cigarettes
- Wake Forest University Health Sciences, Winston-Salem
RekruttererTidlig fase 1Frivillige helsepersonell ønskes velkommen
Alder 21 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT05707871A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
- Wake Forest University Health Sciences, Winston-Salem
RekruttererObservasjonsstudie
Alder 7 og eldre · Alle kjønn · Oppdatert 25. aug. 2026 · NCT05705531A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Asheville
- Research Site, Chapel Hill
- Research Site, Charlotte
- og 11 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Duke University Health System, Durham
- Moses H Cone Memorial Hospital, Greensboro
- Medication Management LLC, Greensboro
- og 6 flere
RekruttererFase 3
Alder 50 til 105 · Alle kjønn · Oppdatert 21. aug. 2026 · NCT07136012Global Paradise System US Post Approval Study
- University of North Carolina at Chapel Hill School of Medicine, Chapel Hill
- Durham VA Health System, Durham
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 12. aug. 2026 · NCT06297291Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
- Wake Forest University Baptist Medical Center, Winston-Salem
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 7. aug. 2026 · NCT06813911PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- UNC Medical Center, Durham
- Duke University, Durham
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 29. jun. 2026 · NCT05934487SPYRAL GEMINI Pilot Study
- University of North Carolina (UNC) Memorial Hospital, Chapel Hill
Rekrutterer
Alder 18 til 80 · Alle kjønn · Oppdatert 24. jun. 2026 · NCT06907147Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- University of North Carolina at Chapel Hill, Chapel Hill
- Carolinas Medical Center, Charlotte
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 10. jun. 2026 · NCT06526195Sequential Multiple Assignment Randomized Trial to Reduce Food Insecurity
- Wake Forest University Health Sciences, Winston-Salem
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 6. mai 2026 · NCT07031739Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
- Wake Forest University Health Sciences, Winston-Salem
RekruttererFase 2
Alder 40 til 75 · Alle kjønn · Oppdatert 27. feb. 2026 · NCT06488105PKP2-ACM Natural History Study
- Duke University, Durham
RekruttererObservasjonsstudie
Alder 12 og eldre · Alle kjønn · Oppdatert 27. feb. 2026 · NCT06644742Beta-Blocker Influences on Inflammatory and Neural Responses to Stress
- Social Neuroscience and Health Laboratory, Chapel Hill
RekruttererFase 4Frivillige helsepersonell ønskes velkommen
Alder 18 til 30 · Alle kjønn · Oppdatert 29. okt. 2025 · NCT06263452MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- NC Heart and Vascular Research, LLC, Raleigh
Rekrutterer
Alder 18 til 80 · Alle kjønn · Oppdatert 11. sep. 2025 · NCT06271590MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- NC Heart and Vascular Research, LLC, Raleigh
Rekrutterer
Alder 18 til 110 · Alle kjønn · Oppdatert 25. feb. 2025 · NCT05908331Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation Programs
- Mission Health, Asheville
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 21. mai 2024 · NCT06424119Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.